Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
about
Bioprosthetic heart valves of the futureValved conduit with glutaraldehyde-fixed bovine pericardium treated by anticalcification protocol.Changes of the Structural and Biomechanical Properties of the Bovine Pericardium after the Removal of α-Gal Epitopes by Decellularization and α-Galactosidase TreatmentInflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview.Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves.Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair.Stabilized collagen scaffolds for heart valve tissue engineering.Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.Does implantation of larger bioprosthetic pulmonary valves in young patients guarantee durability in adults? Durability analysis of stented bioprosthetic valves in the pulmonary position in patients with Tetralogy of Fallot†.Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves.Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage.Evaluation of a novel tetra-functional branched poly(ethylene glycol) crosslinker for manufacture of crosslinked, decellularized, porcine aortic valve leaflets.Prosthetic Aortic Valves: Challenges and Solutions.
P2860
Q28829371-E2D1A68B-3E9B-4D90-B078-8F4B6818033AQ34148345-42488A1D-BC0B-454A-8D67-7BF5E7C9D580Q34527821-175F6065-1981-439B-9347-CBAD56A6A1D9Q35094708-3E3C649A-F156-4967-AEC0-53711E5C0017Q36487601-F039EFD5-17B0-4B16-8A55-94AE49FED59DQ37427563-DE60EEDD-306B-4883-A40C-989ABCF1EA13Q37471571-9A32A30F-C4D6-42F8-A7D5-EFDA7FBC0E31Q38785768-97F69B8A-EF14-45E2-BF96-D24A711FC16FQ39113169-D8C2E405-07CC-4F93-A1A5-C587A61052AFQ40589028-A374C003-7FBF-4823-859C-DAF7EF6AE502Q42026083-9132345E-3301-4D15-BBAF-BD8544C621D2Q43105160-40C847D7-66CA-45B3-8616-7C64DF51F3ECQ54783358-6307FF7F-D18F-4911-A1A8-4C02FDEE780EQ55251699-27614238-D9F4-458B-9800-C27133B9DFF3
P2860
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@ast
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@en
type
label
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@ast
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@en
prefLabel
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@ast
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@en
P2860
P1476
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.
@en
P2093
Dan T Simionescu
P2860
P304
P356
10.1517/14712598.4.12.1971
P407
P577
2004-12-01T00:00:00Z